Press release
Sialorrhea Treatment Market 2034: EMA, PDMA, FDA Approvals, Medication, Clinical Trials, Revenue, Statistics, Therapies, Prevalence, Companies by DelveInsight
Sialorrhea Treatment Market
The Sialorrhea market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Sialorrhea market size from 2020 to 2034, segmented by seven major markets. The Report also covers current Sialorrhea treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assesses the underlying potential of the Sialorrhea market.
Discover which therapies are expected to grab the Sialorrhea Market Share @ Sialorrhea Market Outlook- https://www.delveinsight.com/sample-request/sialorrhea-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Key Takeaways from the Sialorrhea Market Report
• In 7MM, the United States accounts for the highest number of prevalent cases of Sialorrhea in 2023.
• In the United States around 3,36,800 cases of Chronic Sialorrhea in Parkinson's disease were present in 2023.
• Amongst EU4 and the UK, Germany had the highest prevalent population of Sialorrhea, followed by the United Kingdom. On the other hand, Spain had the lowest diagnosed prevalent population in 2023.
• The leading Sialorrhea Companies such as Orient Pharma Co., Ltd, Supernus Pharmaceuticals, Inc., NeuroHealing Pharmaceuticals Inc., Merz Pharmaceuticals GmbH, Solstice Neurosciences, and others.
• Promising Sialorrhea Pipeline Therapies such as NT 201, Oral Glycopyrrolate Liquid, NH004 tropicamide, MYOBLOC, and others.
Stay ahead in the Sialorrhea Therapeutics Market with DelveInsight's Strategic Report @ Sialorrhea Market Outlook- https://www.delveinsight.com/sample-request/sialorrhea-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Sialorrhea Epidemiology Segmentation in the 7MM
• Total Sialorrhea Prevalent Cases of Selected Indications
• Total Prevalent Cases of Sialorrhea in Selected Indications
• Total Prevalent Cases of Chronic Sialorrhea in Selected Indications
Download the report to understand which factors are driving Sialorrhea Epidemiology trends @ Sialorrhea Prevalence- https://www.delveinsight.com/sample-request/sialorrhea-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Sialorrhea Marketed Drug
• MYOBLOC (rimabotulinumtoxinB): US WorldMeds
MYOBLOC is the first and only FDA-approved botulinum toxin B for the treatment of chronic Sialorrhea (excessive drooling) in adults. MYOBLOC is an acetylcholine release inhibitor that blocks cholinergic transmission at the neuromuscular and salivary neuroglandular junction by inhibiting the release of acetylcholine from peripheral cholinergic nerve terminals. MYOBLOC was first approved by the US Food and Drug Administration (FDA) for cervical dystonia in December 2000. US WorldMeds submitted a supplemental biologics license application (sBLA) for the drug to the FDA for the treatment of chronic Sialorrhea in October 2018. MYOBLOC was approved for the condition in August 2019. The drug is marketed in Europe by US WorldMeds' subsidiary Sloan Pharma along with Eisai, under the brand name NEUROBLOC, for the treatment of cervical dystonia. Eisai develops and markets the drug in Japan under the brand name NERBLOC for the same indication.
• XEOMIN: Merz Pharmaceuticals
XEOMIN (incobotulinumtoxinA) for injection is indicated for the treatment of Chronic Sialorrhea in patients 2 years of age and older. In July 2018, the US FDA approved XEOMIN for chronic or excessive drooling (Sialorrhea) in adult patients. In December 2020, Merz Therapeutics announced that the US FDA has approved a sBLA for XEOMIN for the treatment of patients aged 2 years and older with chronic Sialorrhea, or drooling. XEOMIN is the first and only FDA-approved neuromodulator with this indication and was granted a priority review designation upon acceptance by the FDA. XEOMIN gained European approval for treating Chronic Sialorrhea in children in 2021, while its approval for adult patients dates back to 2019.
Transitional Cell Carcinoma Treatment Landscape
Treating Sialorrhea is a difficult process and requires group efforts. The aim is to reduce or stop excess salivation. Current treatment practices vary among practitioners. Traditional treatment options include daily oral medications to diminish saliva production, periodic injections of a medication called Botox for a temporary reduction in saliva production, or a variety of open surgical procedures to remove some salivary glands or disconnect others from the mouth. Thus, the treatment ranges from conservative to more invasive treatment methods. Changes in diet or habits, oral-motor exercises, intra-oral devices such as palatal training devices, and medical treatments such as medication or botulinum toxin injections constitute conservative methods of treatment.
To learn more about Sialorrhea treatment guidelines, visit @ Sialorrhea Treatment Market Landscape- https://www.delveinsight.com/sample-request/sialorrhea-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Sialorrhea Market Outlook
Anticholinergic agents like glycopyrrolate are commonly used, with oral solutions like CUVPOSA gaining popularity due to their acceptability among children. Additionally, botulinum toxins, particularly Xeomin, have emerged as effective alternatives with fewer side effects, gaining FDA approval in the US and EMA approval in Europe. Market-wise, the landscape has seen significant shifts, especially with the introduction of MYOBLOC and other botulinum toxin formulations. These approved treatments are expected to dominate the market, reducing the reliance on off-label use of unlicensed products. Furthermore, ongoing research and development, including promising candidates like NT004, and OP-014 indicate a future trend towards targeted therapies with improved efficacy and reduced side effects, shaping a more optimistic outlook for Sialorrhea management.
Learn more about the FDA-approved drugs for Sialorrhea @ Drugs for Sialorrhea Treatment-https://www.delveinsight.com/sample-request/sialorrhea-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Scope of the Sialorrhea Market Report
• Coverage- 7MM
• Study Period- 2020-2034
• Sialorrhea Companies- Orient Pharma Co., Ltd, Supernus Pharmaceuticals, Inc., NeuroHealing Pharmaceuticals Inc., Merz Pharmaceuticals GmbH, Solstice Neurosciences, and others.
• Sialorrhea Pipeline Therapies- NT 201, Oral Glycopyrrolate Liquid, NH004 tropicamide, MYOBLOC, and others.
• Sialorrhea Market Dynamics: Sialorrhea Market Drivers and Barriers
• Sialorrhea Market Access and Reimbursement, Unmet Needs and Future Perspectives
Discover more about Sialorrhea Drugs in development @ Sialorrhea Clinical Trials Assessment- https://www.delveinsight.com/sample-request/sialorrhea-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Table of Content
1. Key Insights
2. Sialorrhea Report Introduction
3. Executive Summary of Sialorrhea
4. Key Events
5. Sialorrhea Epidemiology and Market Forecast Methodology
6. Sialorrhea Market Overview at a Glance
7. Disease Background and Overview: Sialorrhea
8. Sialorrhea Treatment and Management
9. Sialorrhea Epidemiology and Patient Population
10. Sialorrhea Patient Journey
11. Sialorrhea Marketed Drugs
12. Sialorrhea: 7MM Analysis
13. Sialorrhea Unmet Needs
14. Sialorrhea SWOT Analysis
15. Sialorrhea KOL Views
16. Sialorrhea Market Access and Reimbursement
17. Appendix
18. DelveInsight Capabilities
19. Disclaimer
20. About DelveInsight
Related Reports:
• Trigeminal Neuralgia Market Size: https://www.delveinsight.com/report-store/chronic-pain-market
• Ventricular Fibrillation Market: https://www.delveinsight.com/report-store/electrophysiology-devices-market
• Adamantinoma Market: https://www.delveinsight.com/blog/bone-cancer-treatment-market
• Healthcare Subscription Models: https://www.delveinsight.com/blog/subscription-model-in-healthcare
• Healthcare Competitive Benchmarking: https://www.delveinsight.com/consulting/competitive-benchmarking-services
• Capnography Device Market: https://www.delveinsight.com/report-store/capnography-devices-market
• Benefits Of Robotics In Healthcare: https://www.delveinsight.com/blog/robotics-in-healthcare
• Wound Irrigation Systems Market: https://www.delveinsight.com/report-store/wound-irrigation-systems-market?utm_source=Medgadget&utm_medium=pressrelease&utm_campaign=kupr
• Pulse Oximeter Market: https://www.delveinsight.com/report-store/pulse-oximeters-market
• Gaucher Disease Market: https://www.delveinsight.com/report-store/gauchers-disease-market
• Anti-cd274 Pd-l1 Antibody Pipeline: https://www.delveinsight.com/report-store/pd-1-and-pd-l1-inhibitors-competitive-landscape
• Apheresis Market: https://www.delveinsight.com/report-store/apheresis-market
• Atherectomy Devices Market: https://www.delveinsight.com/report-store/atherectomy-devices-market
• Hearing Implants Market: https://www.delveinsight.com/report-store/hearing-implants-market
• Menopause Market: https://www.delveinsight.com/report-store/menopause-market
• Ophthalmic Imaging Equipment Market: https://www.delveinsight.com/report-store/ophthalmic-imaging-equipment-market
• Aortic Aneurysm Stent Grafts Market: https://www.delveinsight.com/report-store/aortic-aneurysm-stent-grafts-market
• Blood Glucose Monitoring Systems Market: https://www.delveinsight.com/report-store/blood-glucose-monitoring-systems-market
• Chronic Lymphocytic Leukemia Cll Market: https://www.delveinsight.com/report-store/chronic-lymphocytic-leukemia-cll-market
• Healthcare Due Diligence Services: https://www.delveinsight.com/consulting/due-diligence-services
• Pressure Ulcers Market: https://www.delveinsight.com/report-store/pressure-ulcers-market
• Pulse Oximeters Market: https://www.delveinsight.com/report-store/pulse-oximeters-market
• Diabetic Foot Ulcers Dfus Market: https://www.delveinsight.com/report-store/diabetic-foot-ulcers-dfus-market
• Energy Based Aesthetic Devices Market: https://www.delveinsight.com/report-store/energy-based-aesthetic-devices-market
• Hepatitis B Virus Market: https://www.delveinsight.com/report-store/chronic-hepatitis-b-virus-market
• Minimal Residual Disease Market: https://www.delveinsight.com/report-store/minimal-residual-disease-market
• Vertigo Market: https://www.delveinsight.com/report-store/vertigo-market
• Chronic Hepatitis B Virus Market: https://www.delveinsight.com/report-store/chronic-hepatitis-b-virus-market
• Neuroprosthetics Market: https://www.delveinsight.com/blog/neuroprosthetics-market-analysis
• Non Alcoholic Fatty Liver Disease Nafld Market: https://www.delveinsight.com/report-store/non-alcoholic-fatty-liver-disease-nafld-market
• Palmar Hyperhidrosis Market: https://www.delveinsight.com/report-store/palmar-hyperhidrosis-market
• Acute Pain Market: https://www.delveinsight.com/report-store/acute-pain-market
• Automated External Defibrillators Market: https://www.delveinsight.com/report-store/external-defibrillators-market
• Dysthymia Market: https://www.delveinsight.com/report-store/persistent-depressive-disorder-market?utm_source=globenewswire&utm_medium=pressrelease&utm_campaign=spr
• Interbody Cages Market: https://www.delveinsight.com/report-store/interbody-cages-market
• Osteoarthritis Market: https://www.delveinsight.com/report-store/knee-osteoarthritis-market
• Palmar Hyperhidrosis Market Size: https://www.delveinsight.com/report-store/palmar-hyperhidrosis-market
• Wet-age Related Macular Degeneration Market: https://www.delveinsight.com/report-store/wet-age-related-macular-degeneration-wet-amd-market
• X Linked Hypophosphatemia Market: https://www.delveinsight.com/report-store/x-linked-hypophosphatemia-market
• Absssi Market Size: https://www.delveinsight.com/report-store/acute-bacterial-skin-and-skin-structure-infections-market
• Age-related Macular Degeneration Market: https://www.delveinsight.com/report-store/age-related-macular-degeneration-amd-market
• Androgenetic Alopecia Market: https://www.delveinsight.com/report-store/androgenetic-alopecia-market
• Arthroscopy Devices Market: https://www.delveinsight.com/report-store/arthroscopy-devices-market
• Artificial Kidney Market: https://www.delveinsight.com/report-store/artificial-kidney-market
• Carpal Tunnel Syndrome Market: https://www.delveinsight.com/report-store/carpal-tunnel-syndrome-market
• Central Pain Syndrome Market: https://www.delveinsight.com/report-store/central-pain-syndrome-market
• Cough Assisted Device Market: https://www.delveinsight.com/report-store/cough-assist-devices-market
• Duchenne Muscular Dystrophy Market: https://www.delveinsight.com/blog/duchenne-muscular-dystrophy-market
• Hearing Aid Devices Market: https://www.delveinsight.com/report-store/audiology-devices-market
• Neurovascular Devices Market: https://www.delveinsight.com/report-store/neurovascular-devices-interventional-neurology-market
• Prefilled Syringes Market: https://www.delveinsight.com/report-store/prefilled-syringes-market
• Xerostomia Market: https://www.delveinsight.com/report-store/xerostomia-market
Contact Us:
Ankit Nigam
Manager Marketing
info@delveinsight.com
+14699457679
https://www.delveinsight.com/ats-conference-coverage
About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Sialorrhea Treatment Market 2034: EMA, PDMA, FDA Approvals, Medication, Clinical Trials, Revenue, Statistics, Therapies, Prevalence, Companies by DelveInsight here
News-ID: 4016533 • Views: …
More Releases from DelveInsight Business Research
Tuberous Sclerosis Complex Drugs Market 2034: Clinical Trials, EMA, PDMA, FDA Ap …
(Albany, USA) DelveInsight's "Tuberous Sclerosis Complex Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of the Tuberous Sclerosis Complex, historical and forecasted epidemiology as well as the Tuberous Sclerosis Complex market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.
The Tuberous Sclerosis Complex market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the…
Wilson's Disease Drugs Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, M …
(Albany, USA) DelveInsight's "Wilson's Disease Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Wilson's Disease, historical and forecasted epidemiology as well as the Wilson's Disease market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
The Wilson's Disease market report also offers comprehensive insights into the Wilson's Disease market size, share, Wilson's Disease epidemiology, emerging therapies, market drivers and barriers,…
Fabry Disease Drugs Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Medi …
(Albany, USA) DelveInsight's "Fabry Disease Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of Fabry Disease, historical and forecasted epidemiology as well as the Fabry Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Fabry Disease market report provides current treatment practices, emerging drugs, the market share of tmarkets. The Report also covers current Fabry Disease treatment practice/algorithm, market…
Eisenmenger Complex Drugs Market 2032: Clinical Trials, EMA, PDMA, FDA Approvals …
(Albany, USA) DelveInsight's "Eisenmenger Complex Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Eisenmenger Complex, historical and forecasted epidemiology as well as the Eisenmenger Complex market trends in the United States, EU4 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.
The Eisenmenger Complex market report provides current treatment practices, emerging drugs, the Eisenmenger Complex market share of individual therapies, and current and forecasted Eisenmenger…
More Releases for Sialorrhea
Botulinum Toxin Market Is To Be Driven By Digitized Data Collection At A CAGR Of …
The Botulinum Toxin Market is slated to grow at a gracious rate of 6.9%, reaching US$ 10.7 Bn by the year 2031. With value-oriented approach being the need of the hour, the healthcare vertical is likely to go the technologically advanced way in the next 10 years. With Big Data, AI comprising these advancements, the healthcare vertical is bound to create greater strides going forward.
As per Persistence Market Research's latest…
Botulinum Toxin Market 2022 Global Projection By Key Players - Allergan PLC, U.S …
Botulinum Toxin Market is slated to grow at a gracious rate of 6.9%, reaching US$ 10.7 Bn by the year 2031. With value-oriented approach being the need of the hour, the healthcare vertical is likely to go the technologically advanced way in the next 10 years. With Big Data, AI comprising these advancements, the healthcare vertical is bound to create greater strides going forward.
As per Persistence Market Research's latest industry…
The Botulinum Toxin Market to gloat over digitized development-oriented teasers …
The Botulinum Toxin Market is slated to grow on a decent note, i.e. witness a CAGR of 6.9% from 2021-2031. Workflows are getting streamlined due to increased connectivity and quicker internet. This is an era of medical IoT, which goes on to implement wearable devices and several other integrated applications for catering to healthcare needs. This would continue shortly as well.
As per Persistence Market Research's latest industry analysis, the global…
The period from 2021-2031 cast an innovation-oriented shadow on Botulinum Toxin …
The Botulinum Toxin Market is likely to grow at an impertinent level shortly. Chabot's powered by machine learning is the transformation of the way interaction amongst patients happens. Machine learning is there to help radiologists to identify differences in the scans. This, in turn, helps them in diagnosing and detecting health issues, that too, at an early stage. This is the ongoing trend in the healthcare vertical and the status…
Healthcare CRO to Be the Prevailing Trend in the Botulinum Toxin Market
The Botulinum Toxin Market is likely to grow stupendously in the subsequent decade. With IoT in the picture, the complex medical equipment could be monitored, that too, all at a time and under one umbrella. As such, costly downtime could be avoided and predictive maintenance could be fostered. Plus, increased spending could be facilitated for disposable items like syringes, gloves, and masks.
As per Persistence Market Research's latest industry analysis, the…
Healthcare CRO to Be the Prevailing Trend in the Botulinum Toxin Market
The Botulinum Toxin Market is bound to grow robustly in the years to come. With smart technology and 5G being increasingly adopted, the healthcare vertical is witnessing a paradigm shift. These technologies can thus increase the convenience quotient (CQ), as abysmal disruption happens in the patients' lives. This convenience quotient would be the trend running in the healthcare vertical shortly.
As per Persistence Market Research's latest industry analysis, the global botulinum…
